Filgrastim-sndz debuts as the first biosimilar approved in United StatesDecember 14, 2015Patient & Survivor Care
Dinutuximab combination therapy becomes first approval for high-risk neuroblastomaOctober 19, 2015GastroenterologyImmunotherapyGastrointestinal Cancer
Panobinostat: a novel mechanism of action shows promise in multiple myelomaAugust 25, 2015Lymphoma & Plasma Cell Disorders
Blinatumomab for hard-to-treat form of acute lymphoblastic leukemiaMay 13, 2015Leukemia, Myelodysplasia, Transplantation
Palonosetron and netupitant for prevention of chemotherapy-induced nausea and vomitingApril 21, 2015Patient & Survivor CareBreast CancerGastroenterologyGenitourinary CancerGastrointestinal Cancer
Palbociclib and letrozole for ER-positive, HER2-negative advanced breast cancerMarch 16, 2015Breast CancerPatient & Survivor Care
Ramucirumab for advanced gastric or GEJ adenocarcinoma in previously treated patients with disease progressionDecember 17, 2014GastroenterologyGastrointestinal Cancer
Mechlorethamine gel for early stage mycosis fungoides-type CTCLAugust 27, 2014Lymphoma & Plasma Cell Disorders
Trametinib plus dabrafenib for unresectable or metastatic melanoma with BRAF V600E or V600K mutationsJuly 22, 2014Melanoma
Obinutuzumab for previously untreated chronic lymphocytic leukemiaApril 22, 2014Leukemia, Myelodysplasia, Transplantation
